Critically ill cancer patients in the intensive care unit: Short-term outcome and 1-year mortality

Acta Anaesthesiologica Scandinavica

Volumn 56, Issue 2, 2012, Pages 178-189

  Mokart, D ^a   Etienne, A ^a   Esterni, B ^a   Brun, J P ^a   Chow Chine, L ^a   Sannini, A ^a   Faucher, M ^a   Blache, J L ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVOR; CRITICALLY ILL PATIENT; FEMALE; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; NEUTROPENIA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; VIRUS INFECTION;

AGED; APACHE; COMORBIDITY; CRITICAL ILLNESS; FEMALE; HOSPITAL MORTALITY; HUMANS; INFECTION; INTENSIVE CARE; INTENSIVE CARE UNITS; LENGTH OF STAY; LOD SCORE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEOPLASMS; PATIENT DISCHARGE; PROGNOSIS; PROSPECTIVE STUDIES; RESPIRATORY INSUFFICIENCY; SURVIVAL ANALYSIS; SURVIVORS; TREATMENT OUTCOME;

EID: 84855785091     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2011.02579.x     Document Type: Article

References (54)

1. Azoulay E, Recher C, Alberti C, Soufir L, Leleu G, Le G Jr, Fermand JP, Schlemmer B,. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 1999; 25: 1395-1401. (Pubitemid 30021166)
2. Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB,. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999; 160: 1957-1961. (Pubitemid 30004703)
3. Larche J, Azoulay E, Fieux F, Mesnard L, Moreau D, Thiery G, Darmon M, Le Gall JR, Schlemmer B,. Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 2003; 29: 1688-1695. (Pubitemid 37373811)
4. Pene F, Percheron S, Lemiale V, Viallon V, Claessens YE, Marque S, Charpentier J, Angus DC, Cariou A, Chiche JD, Mira JP,. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med 2008; 36: 690-696.
5. Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, Burgmann H, Wilfing A, Kofler J, Thalhammer F, Frass M,. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000; 28: 1322-1328. (Pubitemid 30324501)
6. Vandijck DM, Benoit DD, Depuydt PO, Offner FC, Blot SI, Van Tilborgh AK, Nollet J, Steel E, Noens LA, Decruyenaere JM,. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 2008; 34: 847-855.
7. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den NE, Salles G, Gaulard P, Reyes F, Lederlin P, Gisselbrecht C,. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-242. (Pubitemid 34438862)
8. Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA,. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408-2417. (Pubitemid 44903745)
9. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud JP,. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 2001; 344: 481-487. (Pubitemid 32164899)
10. Azoulay E, Afessa B,. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med 2006; 32: 3-5. (Pubitemid 43039368)
11. Groeger JS, Bach PB,. Consider saying yes. Crit Care Med 2003; 31: 320-321. (Pubitemid 36151199)
12. Azoulay E, Moreau D, Alberti C, Leleu G, Adrie C, Barboteu M, Cottu P, Levy V, Le G Jr, Schlemmer B,. Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med 2000; 26: 1817-1823. (Pubitemid 32009999)
13. Darmon M, Azoulay E, Alberti C, Fieux F, Moreau D, Le G Jr, Schlemmer B,. Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med 2002; 28: 1775-1780. (Pubitemid 35435480)
14. Khassawneh BY, White P Jr, Anaissie EJ, Barlogie B, Hiller FC,. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 2002; 121: 185-188. (Pubitemid 34114245)
15. Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E,. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808-814. (Pubitemid 46407795)
16. Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A, Installe E,. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 2002; 30: 2260-2270. (Pubitemid 35191577)
17. Berghmans T, Paesmans M, Sculier JP,. Is a specific oncological scoring system better at predicting the prognosis of cancer patients admitted for an acute medical complication in an intensive care unit than general gravity scores? Support Care Cancer 2004; 12: 234-239. (Pubitemid 38660745)
18. Guiguet M, Blot F, Escudier B, Antoun S, Leclercq B, Nitenberg G,. Severity-of-illness scores for neutropenic cancer patients in an intensive care unit: Which is the best predictor? Do multiple assessment times improve the predictive value? Crit Care Med 1998; 26: 488-493. (Pubitemid 28141484)
19. Soares M, Fontes F, Dantas J, Gadelha D, Cariello P, Nardes F, Amorim C, Toscano L, Rocco JR,. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study. Crit Care 2004; 8: R194-203.
20. Thiery G, Azoulay E, Darmon M, Ciroldi M, de, Miranda S, Levy V, Fieux F, Moreau D, Le Gall JR, Schlemmer B,. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23: 4406-4413. (Pubitemid 46207015)
21. Charlson ME, Sax FL, MacKenzie CR, Braham RL, Fields SD, Douglas RG Jr,. Morbidity during hospitalization: can we predict it? J Chronic Dis 1987; 40: 705-712. (Pubitemid 17113477)
22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE,. Prognosis in acute organ-system failure. Ann Surg 1985; 202: 685-693. (Pubitemid 16229382)
23. Le G Jr, Lemeshow S, Saulnier F,. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-2963. (Pubitemid 24000804)
24. Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D,. The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 1996; 276: 802-810. (Pubitemid 26301580)
25. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R,. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824. (Pubitemid 24082248)
26. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874.
27. Azoulay E, Mokart D, Rabbat A, Pene F, Kouatchet A, Bruneel F, Vincent F, Hamidfar R, Moreau D, Mohammedi I, Epinette G, Beduneau G, Castelain V, De Lassence A, Gruson D, Lemiale V, Renard B, Chevret S, Schlemmer B,. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 2008; 36: 100-107.
28. Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, Gibran NS, Huang ML, Santo Hayes TK, Corey L, Boeckh M,. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008; 300: 413-422. (Pubitemid 352040253)
29. Gentile G, Donati PP, Capobianchi A, Rolli M, Iori AP, Martino P,. Evaluation of a score system for the severity and outcome of cytomegalovirus interstitial pneumonia in allogeneic bone marrow recipients. J Infect 1997; 35: 117-123. (Pubitemid 27464679)
30. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ,. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14. (Pubitemid 33152659)
31. Benoit DD, Hoste EA, Depuydt PO, Offner FC, Lameire NH, Vandewoude KH, Dhondt AW, Noens LA, Decruyenaere JM,. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant 2005; 20: 552-558. (Pubitemid 40378424)
32. Esteban A, Anzueto A, Frutos F, Alia I, Brochard L, Stewart TE, Benito S, Epstein SK, Apezteguia C, Nightingale P, Arroliga AC, Tobin MJ,. Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study. JAMA 2002; 287: 345-355. (Pubitemid 34251968)
33. Strand K, Flaatten H,. Severity scoring in the ICU: a review. Acta Anaesthesiol Scand 2008; 52: 467-478. (Pubitemid 351392864)
34. Soares M, Caruso P, Silva E, Teles JM, Lobo SM, Friedman G, Dal PF, Mello PV, Bozza FA, Silva UV, Torelly AP, Knibel MF, Rezende E, Netto JJ, Piras C, Castro A, Ferreira BS, Rea-Neto A, Olmedo PB, Salluh JI,. Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med 2010; 38: 9-15.
35. Vincent JL, Moreno R,. Clinical review: scoring systems in the critically ill. Crit Care 2010; 14: 207-213.
36. Timsit JF, Fosse JP, Troche G, De Lassence A, Alberti C, Garrouste-Org M, Bornstain C, Adrie C, Cheval C, Chevret S,. Calibration and discrimination by daily Logistic Organ Dysfunction scoring comparatively with daily Sequential Organ Failure Assessment scoring for predicting hospital mortality in critically ill patients. Crit Care Med 2002; 30: 2003-2013.
37. Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ, Champlin RE, Aguilera EA, Tarrand JJ, Raad II,. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine 2006; 85: 278-287. (Pubitemid 44401460)
38. Martino R, Porras RP, Rabella N, Williams JV, Ramila E, Margall N, Labeaga R, Crowe JE Jr, Coll P, Sierra J,. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 2005; 11: 781-796. (Pubitemid 41403760)
39. Nichols WG, Guthrie KA, Corey L, Boeckh M,. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300-1306. (Pubitemid 39458515)
40. Cameron RJ, de Wit D, Welsh TN, Ferguson J, Grissell TV, Rye PJ,. Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med 2006; 32: 1022-1029. (Pubitemid 43952717)
41. Bruynseels P, Jorens PG, Demey HE, Goossens H, Pattyn SR, Elseviers MM, Weyler J, Bossaert LL, Mentens Y, Ieven M,. Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. Lancet 2003; 362: 1536-1541. (Pubitemid 37410191)
42. Luyt CE, Combes A, Deback C, ubriot-Lorton MH, Nieszkowska A, Trouillet JL, Capron F, Agut H, Gibert C, Chastre J,. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 2007; 175: 935-942. (Pubitemid 46684704)
43. Azoulay E, Thiery G, Chevret S, Moreau D, Darmon M, Bergeron A, Yang K, Meignin V, Ciroldi M, Le Gall JR, Tazi A, Schlemmer B,. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine 2004; 83: 360-370. (Pubitemid 39545182)
44. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA,. The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009; 15: 496-497.
45. Christiansen CF, Christensen S, Johansen MB, Larsen KM, Tonnesen E, Sorensen HT,. The impact of pre-admission morbidity level on 3-year mortality after intensive care: a Danish cohort study. Acta Anaesthesiol Scand 2011; 55: 962-970.
46. Schellongowski P, Staudinger T, Kundi M, Laczika K, Locker GJ, Bojic A, Robak O, Fuhrmann V, Jager U, Valent P, Sperr WR,. Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica 2011; 96: 231-237.
47. Thakkar SG, Fu AZ, Sweetenham JW, Mciver ZA, Mohan SR, Ramsingh G, Advani AS, Sobecks R, Rybicki L, Kalaycio M, Sekeres MA,. Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit. Cancer 2008; 112: 2233-2240. (Pubitemid 351628634)
48. Etienne A, Esterni B, Charbonnier A, Mozziconacci MJ, Arnoulet C, Coso D, Puig B, Gastaut JA, Maraninchi D, Vey N,. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia. Cancer 2007; 109: 1376-1383. (Pubitemid 46466565)
49. Kantarjian H, O'Brien S, Cortes J, Giles F, Faderl S, Jabbour E, Garcia-Manero G, Wierda W, Pierce S, Shan J, Estey E,. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer 2006; 106: 1090-1098.
50. Peigne V, Rusinova K, Karlin L, Darmon M, Fermand JP, Schlemmer B, Azoulay E,. Continued survival gains in recent years among critically ill myeloma patients. Intensive Care Med 2009; 35: 512-518.
51. Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG, Monconduit M, Hulin C, Caillot D, Bouabdallah R, Voillat L, Sotto JJ, Grosbois B, Bataille R,. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 2003; 349: 2495-2502. (Pubitemid 38010075)
52. Dimopoulos M, Spencer A, Attal M, Prince HM, Harousseau JL, Dmoszynska A, San MJ, Hellmann A, Facon T, Foa R, Corso A, Masliak Z, Olesnyckyj M, Yu Z, Patin J, Zeldis JB, Knight RD,. Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med 2007; 357: 2123-2132. (Pubitemid 350146107)
53. Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine DL, Kauffman M, Adams J, Schenkein DP, Anderson KC,. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 2003; 348: 2609-2617. (Pubitemid 36741588)
54. Hill QA,. Intensify, resuscitate or palliate: decision making in the critically ill patient with haematological malignancy. Blood Rev 2010; 24: 17-25.